Potential of Proprotein Convertase Subtilisin/Kexin Type 9 Based Therapeutics

Overview of attention for article published in Current Atherosclerosis Reports, February 2013

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (82nd percentile)

Mentioned by

twitter: 1 X user

patent: 3 patents

Citations

dimensions_citation: 74 Dimensions

Readers on

mendeley: 60 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 1 X post from an account with 450 followers.

Los inhibidores de #PCSK9, un nuevo tratamiento para la hipercolesterolemia? http://t.co/gVwq4nsDVW y http://t.co/cZP9hi0uxE

Reply Repost Favourite